These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1740205)

  • 41. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progesterone response to exogenous gonadotropins after suppression with leuprolide acetate in gamete intrafallopian transfer.
    Riemann DC; Schoolcraft WB; Sinton EB
    J Reprod Med; 1991 Mar; 36(3):190-4. PubMed ID: 1903164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of GnRH agonists in the treatment of failed cycles in an IVF-ET program: a comparative study.
    Feldberg D; Goldman GA; Dicker D; Ashkenazi J; Yeshaya A; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):103-9. PubMed ID: 2137420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
    Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.
    Scott RT; Navot D
    Fertil Steril; 1994 May; 61(5):880-5. PubMed ID: 8174725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
    Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
    J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of the antral follicle count to predict the outcome of assisted reproductive technologies.
    Chang MY; Chiang CH; Hsieh TT; Soong YK; Hsu KH
    Fertil Steril; 1998 Mar; 69(3):505-10. PubMed ID: 9531887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer.
    Dicker D; Goldman JA; Levy T; Feldberg D; Ashkenazi J
    Fertil Steril; 1992 Mar; 57(3):597-600. PubMed ID: 1740204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.
    Palermo R; Amodeo G; Navot D; Rosenwaks Z; Cittadini E
    Fertil Steril; 1988 Feb; 49(2):290-5. PubMed ID: 3123277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization.
    Schmutzler RK; Reichert C; Diedrich K; Wildt L; Diedrich C; Al-Hasani S; van der Ven H; Krebs D
    Hum Reprod; 1988 Oct; 3 Suppl 2():29-33. PubMed ID: 2976414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost of assisted reproductive technologies for a health maintenance organization.
    Hidlebaugh DA; Thompson IE; Berger MJ
    J Reprod Med; 1997 Sep; 42(9):570-4. PubMed ID: 9336753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle.
    Winslow KL; Toner JP; Brzyski RG; Oehninger SC; Acosta AA; Muasher SJ
    Fertil Steril; 1991 Oct; 56(4):711-7. PubMed ID: 1915947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No detrimental effects in delaying initiation of gonadotropin administration after pituitary desensitization with gonadotropin-releasing hormone agonist.
    Chang SY; Lee CL; Wang ML; Hu ML; Lai YM; Chang MY; Soong YK
    Fertil Steril; 1993 Jan; 59(1):183-6. PubMed ID: 8419205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program.
    Parinaud J; Oustry P; Perineau M; Rème JM; Monroziès X; Pontonnier G
    Fertil Steril; 1992 Jun; 57(6):1265-8. PubMed ID: 1534774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders.
    Faber BM; Mayer J; Cox B; Jones D; Toner JP; Oehninger S; Muasher SJ
    Fertil Steril; 1998 May; 69(5):826-30. PubMed ID: 9591487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting pregnancy rates of in vitro fertilization and gamete intrafallopian transfer.
    Chang SY; Soong YK; Chang MY
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):806-11. PubMed ID: 2687434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles.
    Goldberg JM; Miller FA; Friedman CI; Dodds WG; Kim MH
    Fertil Steril; 1991 Feb; 55(2):319-23. PubMed ID: 1991530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
    Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.